<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) is derived from preapoptotic germinal center B cells, although a general loss of B <z:mp ids='MP_0005384'>cell phenotype</z:mp> is noted </plain></SENT>
<SENT sid="1" pm="."><plain>Using quantitative reverse transcription-polymerase chain reaction and miRNA microarray, we determined the microRNA (miRNA) profile of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and compared this with the profile of a panel of B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The two methods showed a strong correlation for the detection of miRNA expression levels </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-specific miRNA included miR-17-92 cluster members, miR-16, miR-21, miR-24, and miR-155 </plain></SENT>
<SENT sid="4" pm="."><plain>Using a large panel of cell lines, we found differential expression between <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and other B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived cell lines for 27 miRNA </plain></SENT>
<SENT sid="5" pm="."><plain>A significant down-regulation in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> compared to non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was observed only for miR-150 </plain></SENT>
<SENT sid="6" pm="."><plain>Next, we performed target gene validation of predicted target genes for miR-155, which is highly expressed in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and is differentially expressed between <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Using luciferase reporter assays, we validated 11 predicted miR-155 target genes in three different <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> cell lines </plain></SENT>
<SENT sid="8" pm="."><plain>We demonstrated that AGTR1, FGF7, ZNF537, ZIC3, and IKBKE are true miR-155 target genes in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
</text></document>